Explore our Clinical Webinar Library to learn about the latest issues and trends within clinical microbiology, and discover advances in blood culture, susceptibility testing
Watch webinars from experts working in the fields of
ECCMID 2022 Resource Center
View and download educational content presented at ECCMID 2022, including:
Symposium:Moving insights into action: How innovative rapid diagnostics impact treatment decisions.
Workshops:
- Evaluation of commercial systems for rapid antimicrobial susceptibility testing (rAST) of positive blood cultures: Comparison of susceptibility results; Q-linea ASTar® System*
- Timely targeted treatments in sepsis: an evaluation of the real-time benefits of the commercial ASTar System* on patient outcome by providing rapid direct blood culture sensitivities in Gram negative organisms
- Laboratory Automation in Microbiology: Accelerating the Impact through AI and Digital Imaging
- Innovative Viral Inactivation Medium for SARS-CoV-2
- Improved midstream urine collection for a higher quality sample that improves antibiotic stewardship
Visit our ECCMID 2022 Resource Center
*Product is CE marked but not 510(k)-cleared and not available for sale in the U.S. Availability of product in each country depends on local regulatory marketing authorization status. Q-linea AB is the legal manufacturer of ASTar®. ASTar® is a trademark of Q-linea AB. All other trademarks are the property of Thermo Fisher Scientific and its subsidiaries. The ASTar system is distributed globally by Thermo Fisher Scientific.
2022 Technical Updates on EUCAST Guidelines
Speaker: Prof. Dr. Sören Gatermann, ESCMID Fellow, Clinical Microbiologist, Chairman of the German NAC, Member of the EUCAST Steering Committee, Ruhr-Universität Bochum, Germany
This webinar addresses changes to the EUCAST breakpoint tables, valid from January 2022 (v12.0) with a focus on:
- Use handling of bracketed breakpoints
- Disk testing of anaerobic bacteria
- Dosing and breakpoints
- How to deal with situations when there are no breakpoints
Sepsis: The Journey Through a Pandemic
Speaker: Dr. Ron Daniels, Executive Director and Founder, UK Sepsis Trust
This webinar highlights the burden of sepsis, explores whether or not progress on sepsis and antimicrobial resistance are mutually incompatible, and discusses the need to re-prioritize sepsis in the wake of the pandemic. It also details the role of the UK Sepsis Trust and other agencies in reducing harm from sepsis and COVID-19.
Topics include:
- The link between sepsis and COVID-19 in terms of pathophysiology, disease risk, and recovery profiles
- The urgent need to re-prioritize sepsis, along with other acute conditions, as we begin to gain control over the pandemic
- How agencies such as the UK Sepsis Trust play a vital role in a systems response to mitigate against harms from infection, and how in vitro diagnostics form an integral part of such a response
Microbiology and Stewardship: Understanding AST Data as a Driver of Antimicrobial Stewardship
Speaker: Professor Romney Humphries, Medical Director of the Microbiology Laboratory, Vanderbilt University Medical Center
Learn how antimicrobial susceptibility testing (AST) data may influence the optimal use of antibiotics and better guide and support your stewardship programs.
Topics include:
Identifying core elements of microbiology lab testing and reporting that promote stewardship
Understanding minimum inhibitory concentration (MIC)-driven therapeutic decisions
Describing antimicrobial therapy challenges in critically ill patients
Multidrug-Resistant Organisms: Improving Time to Effective Treatment
Speaker: Dr. Jose Alexander, Director, Clinical Microbiologist at AdventHealth Orlando
Topics include:
- The impact of beta-lactamase on the effectiveness of existing and new antibiotics?
- What phenotypic tools can be used to predict evolving resistance?
- The impact on patient outcomes and the true cost of therapy (length of stay (LOS), duration of therapy (DOT), antibiotic (ABX) days) when prescribing ineffective treatment?
Antimicrobial Stewardship – Exploring the Pharmacy/Microbiology Laboratory Partnership
Speaker: Dr. Jerod Nagel, PharmD, BCPS (AQID)
Topics include:
- How Antimicrobial Stewardship Programs reduce the risk of inappropriate antimicrobial usage, which can help optimize patient outcomes, as well as reduce costs.
- How the microbiology lab can team up with the pharmacy on AST results that promote antibiotic de-escalation and aid clinical decision-making.
Keeping Up with the Candidas: New Guidelines and Troublesome MICs
Speaker: Jon Faldasz, PharmD BCPS. Infectious Disease Specialist at UCSF Mission Bay
Topics include:
- Changes to Candida testing guidelines and how they impact laboratory practice
- Meaning and implications of S-DD
- Utility of echinocandin susceptibility testing
- Application of Candida antifungal MICs to
clinical isolates
Challenging Bacterial Infections – The Clinical Impact of Critical Microbiology Results
Speaker: James A. McKinnell, MD, Assistant Professor of Medicine, David Geffen School of Medicine, University of California, Los Angeles; Division of Infectious Disease, LA-Biomed at Harbor UCLA Medical Center
Clinicians expect the microbiology laboratory to provide accurate antimicrobial susceptibility testing results to guide their treatment decisions. Reliable susceptibility results are never more important than when addressing today’s most serious bacterial infections including carbapenem-resistant Enterobacteriaceae, Pseudomonas and Acinetobacter. Learn how to steer antibiotic treatment choices that are critical to patient care, including reliable detection of existing and emerging resistance to new drugs, as well as antimicrobials of last resort.
The Diagnostic Challenges of Mycobacterial Infections
Dr. Nathan A. Ledeboer, (Medical College of Wisconsin) speaks about recovery of Mycobacterium from a suspected infection, as well as current and evolving technologies available to microbiology laboratories in the identification and susceptibility testing of mycobacterial infections.
The Race Is On: Faster Turnaround Times in the Diagnosis of Multidrug-Resistant Tuberculosis
Speaker: Max Salfinger, M.D., National Jewish Health
Learn about the changing epidemiology of drug-resistant TB in the United States and globally, as well as the various molecular laboratory assays used to diagnose TB.
Challenges Facing Infant and Pediatric Testing for Blood Infections
Our smallest patients can present challenges in obtaining sufficient samples for blood infection testing. Learn about the standard governing body guidelines available and variables to consider when sampling from this precious patient population.
AMR Through a One Health Approach: Surveillance and Monitoring of Drugs of Last Resort
Find out more ways to protect your most susceptible. Reducing the spread of AMR starts with tailoring antibiotic therapy to patients. Learn how the new Thermo Scientific™ Sensititre™ ARIS HiQ™ System* delivers the insight your team needs to successfully contain infections, expedite appropriate treatment and support antimicrobial surveillance efforts.
Culture maintenance best practices for QC organisms in a clinical laboratory
Is it three passages or five? Is it -70°C or -20°C storage? Come to find answers for best practices and stay compliant to the industry-standard culture maintenance practices. Explore how Thermo Scientific™ Culti-Loops™ enable quick and safe preparation of ATCC®** and NCTC cultures for EUCAST and CLSI routine QC testing.
Addressing the limitations of frontline ID for clinically challenging scenarios
What do you do if your mass spec solution does not give you an interpretable result? Do you have a back-up confirmation method for challenging scenarios? Learn about some quick, simple confirmation tests that can help improve your laboratory workflow and aid patient management.
Thermo Fisher Scientific’s role in the global fight against AMR
Addressing the threat of AMR, what it means for you and what are we doing to ensure you have the most appropriate treatment options for your patients.
Importance of determining true MIC by BMD (Sensititre) in infectious disease management
The success of the management of bacterial infections depends on two main factors. First, the precocity of the diagnostic, and once bacteria are identified, the determination of their antimicrobial susceptibility. This presentation will discuss how the Hospital of Caen, Normandy University overcame the limitations of some widely used AST methods by utilizing broth microdilution (BMD) and obtaining accurate MIC results with Sensititre custom plates.
Tailored Delivery System - Our most efficient prepared media delivery and stock management service
Have you ever thought about ways to reduce your laboratory’s impact on the environment? What if there was a solution that enabled you to decrease waste and costs while improving the efficiency and ergonomics of your prepared media shipments? Learn how you can simplify your inventory management with the new Tailored Delivery System.
Tackling Antimicrobial Resistance: Meeting the Global Challenge of AMR
Learn how the Thermo Scientific™ Sensititre™ System is being used to support microbiology efforts in tackling AMR through a One Health approach.
How do you back up your frontline identification methods?
Problems misidentifying with mass spectrometry? Learn more about the importance of infection confirmation and options for alternative methods in this short video.
Increasing Laboratory Efficiency with Thermo Scientific Bi-plates
Do you need to be more efficient and increase the productivity in your routine lab while reducing costs? Watch now to find out how Thermo Scientific™ bi-plates can help address these challenges.
Why is AST disc quality so important? A few millimeters make the difference!
Do you want to rest assured knowing the AST results you report for your patients are right the first time every time, without unnecessary repeat tests? Watch now to learn more about the critical importance of AST disc quality.
Antimicrobial Susceptibility Testing (AST) Solutions
Satisfy your antimicrobial susceptibility testing (AST) requirements with high performance automated and manual test products to help ensure patients are on the most appropriate treatment plan.
